Prot# LTE5407: Evaluation of the Long-Term Efficacy & Safety of Zolpidem-MR 12.5mg Compared to Placebo, When Both are Administered Over a Long-Term Period "As Needed", in Patients w/Chronic Primary Isomnia (A Randomized, Double-Blind, Placebo-Controlled,

Project: Research project

Project Details

StatusFinished
Effective start/end date3/29/0512/6/06

Funding

  • Sanofi-Synthelabo Inc. (LTE5407)